A sample preparation procedure using microwave energy is proposed for the determination of morphine, 6-acetylmorphine, codeine, cocaine, cocaethylene, benzoylecgonine, methadone, and 2-ethylene-l,5-dimethyl.3,3.diphenylpyrrolidine in human plasma. A screening asymmetrical factorial design was used to identify the most suitable extraction conditions as regards solvent, temperature, and extraction time. The target drugs were quantified by high-performance liquid chromatography with diode-array detection. The use of microwave energy was found to reduce solvent consumption and extraction time compared with solidphase extraction. The detector response was linear over the drug concentration range of 0.05-2.0 pg/mL in human plasma. The precision and accuracy were good, with values less than 8% and 7%, respectively. Drug recoveries from spiked samples ranged from 69 to 81%. The proposed method was successfully applied to a number of forensic cases.
Introduction
Sample preparation is possibly the most important step of the analytical process inasmuch as it has a direct influence on accuracy, representativeness and precision, and hence a direct impact on the quality of the results. Microwave-assisted extraction (MAE) is especially useful with a view to reducing solvent consumption and the preparation time for complex clinical and environmental samples.
The reliability of forensic toxicological analyses depends heavily on appropriate preparation of the samples. There have been major recent developments in extraction methodology including improved solid-phase extraction (SPE) methods (1) (2) (3) , and new solid-phase microextraction (SPME) (4-6) and microwave-based methods (7) (8) (9) (10) (11) (12) . Microwaves constitute a non-ionizing type of radiation spanning the frequency region between radio frequencies and the infrared spectrum. Currently commercially available microwave equipment allows
Author to whom correspondence should be addressed. E-mail: imlpuri@usc.es. the safe, rapid, selective separation of analytes from complex matrices (e.g., the extraction of drugs of abuse from human fluids) at high pressures and temperatures.
This paper reports a new method to prepare human plasma for the determination of morphine, 6-acetylmorphine (6AM), codeine, methadone and its metabolite 2-ethylene-l,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and cocaine and its metabolites benzoylecgonine (BEG) and cocaethylene by the use of microwave energy. The operating conditions were selected as regards solvent, temperature, and extraction time by using a factorial experimental design.
Experimental

Reagents
Standards of morphine, 6AM, cocaine, cocaethylene, BEG, methadone, and EDDP were supplied by Cerilliant (Round Rock, TX). Gradient-grade acetonitrile, methanol, chloroform, and dichloromethane were purchased from Merck (Darmstadt, Germany). Purified water was obtained from a Milli-Q water system from Millipore (Le Mont-sur-Lausanne, Switzerland).
Plasma samples
Drug-free plasma from Transfusion Galician Centre was used for preparation of calibration standards. Plasma samples were obtained from patients on a methadone-maintenance program (MMP), patients in legal custody, patients in Galician Hospitals, and others from fatally poisoned individuals. They were stored refrigerated at 4~ unless the analysis was delayed, in which case the samples were frozen at -18~ All studies were conducted in accordance with the World Medical Association's "Ethical Principles for Medical Research Involving Human Subjects" and the Spanish National Law.
Preparation of calibration standards
Standards containing a 1 mg/mL concentration of each drug in methanol (morphine, codeine, BEG, methadone, and EDDP) or acetonitrile (6AM, cocaine and cocaethylene) were used to prepare working-strength solutions containing a 0.5, 1, 2, 5, 10, or 20 pg/mL concentration of each drug in mobile phase (10:90, v/v, acetonitrile/phosphate buffer, pH 6.5) by appropriate dilution.
Apparatus
The microwave extractor system was an ETHOS PLUS MPR300/12S from Milestone | (Agrigento, Italy) equipped with a solvent detector. The microwave was able to extract 12 samples simultaneously in PTFE-lined extraction closed vessels under the same conditions (temperature and pressure), with simultaneous magnetic stirring of the sample and solvent inside. An in board pressure control system was installed for monitoring and controlling pressure and conditions inside the extraction vessels. This oven allows a maximum of 1000 W and the power changes in order to reach and maintain the temperature selected.
The analyses of the extracts were performed on a model 2695 chromatograph from Waters | (Milford, MA) connected to a model 996 photodiode array detector, also from Waters. Data were processed by using the software Millennium 32 | v. 3.05.01 for Windows 98. Samples were injected onto an XTerra | RP8 stainless steel column (250 mm • 4.6-ram i.d., 5-pm particle size) supplied by Waters.
In order to optimize peak resolution in the chromatograms and efficient separation of the analytes in a reasonably short time (22 rain), elution was done in the gradient mode, using a mobile phase consisting of a mixture of acetonitrile and 20raM phosphate buffer (pH 6.5) at a variable flow rate (Table I) .
The diode-array detector allowed the wavelength range 200-400 nm to be scanned in order to obtain three-dimensional (wavelength x absorbance x time) chromatograms. The sensitivity was optimized by using the wavelengths of maximal chromatographic response for the analytes (specifically, 233 nm for cocaine, BEG, and cocaethylene; 285 nm for morphine, codeine, and 6AM; and 292 nm for methadone and EDDP).
Experimental design
The extraction conditions were selected in an experimental design constructed with the aid of the software Nemrod W. 2000, LPRAI (University ofAix-Marseille III, Marseille, France). Because of the large number of variables potentially affecting the efficiency of microwave assisted extraction, only a few were examined, all others being set at the optimum values found in earlier tests. A screening asymmetrical factorial design of the 2132//9 type was used for this purpose (Table II ). The proposed model is not predictive; rather, it measures response changes at each factor level and then determines interactions. This type of design discards non-significant factors, which reduces the number of tests needed and saves time and expenses as a result (13) . We studied three factors at variable numbers of levels, namely a qualitative factor (solvent) at two levels and two quantitative factors (extraction temperature and time) at three levels each. Variables and levels were selected from a test series conducted prior to constructing the design. In these tests, we tried organic solvents with high affinity with the analytes, such as chloroform, dichloromethane, hexane, toluene, and ethyl acetate. The best results were obtained with chloroform and dichloromethane; therefore, they were included in the design. After analyzing the effect of temperature and time on the process we found that the stability of the studied drugs is no affected in the ranges studied in the design. The experimental domain comprised the following specific variables and levels: solvent (chloroform or dichloromethane), temperature (50, 75, or 100~ and extraction time (1, 5, or 10 rain).
Extraction procedure
A 1-mL sample was mixed with 10 mL of solvent and placed in the vessel of the microwave oven for extraction under the conditions of the particular test as dictated by the experimental design. Following extraction, the vessel contents were centrifuged at 4000 rpm for 20 min and the organic layer was removed for evaporation to dryness under a nitrogen stream in a thermostated bath at 40~ Finally, the dry extract was reconstituted in 100 pL of mobile phase, and a 20-pL aliquot was injected into the chromatograph for analysis.
Results and Discussion
Once the extraction conditions were selected, plasma solutions containing the eight drugs at concentrations of 0.05, 0.1, 0.2, 0.5, 1.0, and 2.0 pg/mL were prepared and extracted in accordance with the described procedure for analysis by HPLC-DAD and construction of calibration curves.
The analytes were identified from their retention times (approximately 6.6. min for morphine, 11.4 rain for codeine, 12.5 rain for BEG, 13.0 rain for 6AM, 15.0 min for cocaine, 16.0 min for cocaethylene, 17.6 rain for EDDP, and 18.6 rain for methadone) and absorption spectra. The HPLC-DAD technique exhibited a high specificity by virtue of its allowing the analytes to be discriminated from other substances with identical retention times potentially present in plasma. Also, it provided a high sensitivity as a result of it allowing the maximum absorption wavelength for each analyte (specifically 233 nm for BEG, cocaine, and cocaethylene; 285 nm for morphine, codeine, and 6AM; and 292 nm for EDDP and methadone) to be monitored.
The calibration curves for the analytes were linear over the concentration range 0.05-2.0 pg/mL in plasma, and their correlation coefficients were all greater than 0.997. A linear regression analysis of the typey ---ax + b provided additional useful parameters such as the slope and intercept (Table III) . By way of example, Figure  1 shows the chromatogram for a plasma sample containing a 0.05 pg/mL concentration of each analyte as monitored at 233 nm.
The chromatographic conditions used to separate the studied drugs were selected from a series of tests involving various types of columns, mobile phases and gradients. 
H Figure 2. Total effect graphics for 6AM (A), BEG (B), cocaethylene (C), cocaine (D), codeine (E), EDDP (F), methadone (G), and morphine (H). The bar units are chromatographic peak area.
Application of the described extraction procedure to drugfree plasma samples revealed the absence of interferences in the chromatographic regions of interest for the analytes.
The results obtained in this work were examined with the aid of graphic tools supplied by the software used (Nemrod) including the total effects graph, the bars in which are proportional in length to the effect of each factor level on the analytical response.
As can be seen in Figure 2 , chloroform provides better responses for 6AM (A), BEG (B), codeine (E), and morphine (H); it appeared as statistically significant effect for these drugs. This solvent practically provides the same effect as dichloromethane for cocaethylene (C), cocaine (D), and methadone (G). Only EDDP (F) presented better responses when dichloromethane was used in MAE. Medium level of temperature (75~ supplied the best responses for four of the drugs: EEDP, BEG, morphine, and codeine. The methadone has shown a better response with 100~ but very short response with 50~ Cocaine and cocaethylene have presented better responses for low value (50~ than medium level (75~ but good responses were also achieved at 75~ both of values were statistically significant for these drugs, but also 75~ has shown statistical signification for morphine and 6AM and almost statistical signification for BEG.
All of the considered drugs show the best responses when high level of time (10 rain) was used in MAE. This level of time was also statistically significant for cocaine, cocaethylene and 6AM. So the most suitable conditions for extracting the eight drugs were as follows: chloroform as solvent, a temperature of 75~ and a time of 10 rain.
Under these conditions, the proposed method was validated in accordance with the recommendations of Shah et al. (14) and Peters and Maurer (15) . The within-day and between-day precision (RSD), and accuracy (relative error), were estimated by subjecting five samples containing the eight drugs at different concentration levels (0.05, 0.5, and 2 g/mL) to the described extraction procedure. The results thus obtained were acceptable; the RSDs were less than 8% and relative errors less than 7% in all cases (Table IV) . These values are similar to those previously obtained by Caufield and Stewart (2) and Foulon et al. (16) .
The limit of quantitation (LOQ) of the method was taken to be the lowest concentration in the calibration curve (0.05 IJg/mL). The limit of detection (LOD), which was taken to be the lowest concentration giving a signal three times as high as the signal-to-noise ratio, was 0.01 lJg/mL for cocaine, cocaethylene and BEG; 0.03 ]~g/mL for morphine, 6AM and methadone; and 0.04 IJg/mL for codeine and EDDP. These LOD values are similar to those previously reported by Brunetto et al. (17) .
Analyte recoveries were determined at two different concentration levels (0.05 and 2.0 IJg/mL). To this end, the mean area under the peak obtained from five replicate analyses of plasma spiked and extracted as described were compared with the mean area under the peak obtained from five replicate samples containing the same analyte concentrations in mobile phase using the following expression:
Recovery (%)= (mean areaplasma/mean areamobilephase)x 100
The recoveries thus calculated ranged from 68% for 6AM to 83% for morphine (Table IV) . These values are similar to those obtained by other authors (18, 19) using SPE. The proposed MAE method is therefore quite robust and can be used for the determination of opiates and cocaine in human plasma. Microwave energy expedites extraction of the analytes while maintaining analyte recovery rates. Because the technique uses standard laboratory equipment, it can be an effective method relative to potential alternatives such as liquid-liquid extraction and SPE; in fact, MAE reduces solvent consumption and
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Once validated, the proposed method was applied to 20 human plasma samples obtained from Galician hospitals and courts (Table V) and 18 others from fatally poisoned individuals obtained from the Institute of Legal Medicine of Galicia (Table  VI) . The results obtained testify to the usefulness of the simultaneous determination of the studied drugs. Thus, three drug consumers (Table V) were found to be consuming heroin, cocaine, and methadone; four heroin and methadone; five cocaine and methadone; and six others heroin and cocaine. Cocaethylene was detected in seven cases, suggesting the simultaneous use of cocaine and alcohol. The average concentrations of the drugs in the plasma samples that tested positive for them were as follows: 0.71 IJg/mL for morphine, 0.80 IJg/mL for codeine, 0.38 ~g/mL for 6AM, 0.76 lJg/mL for BEG, 0.84 IJg/mL for cocaine, 0.42 IJg/mL for cocaethylene, 0.62 IJg/mL for EDDP, and 0.48 IJg/mL for methadone.
The average drug concentrations in the positive samples from fatally poisoned individuals were 0.89 IJg/mL for morphine, 0.99 I~g/mL for codeine, 0.69 ]Jg/mL for 6AM, 1.21 tJg/mL for BEG, 1.03 ~g/mL for cocaine, 1.06 ~g/mL for cocaethylene, 0.73 IJg/mL for EDDP, and 0.90 iJg/mL for methadone. Four individuals (Table VI) were found to have used 3 drugs (heroin, cocaine and methadone), 11 used 2 drugs, and 3 others only 1 drug. The results for cocaine are within the ranges previously obtained by Kroener et al. (21) .
Based on the results, the time elapsed between consumption of the drugs and collection of the samples was quite long. In fact, 6AM, which is the main metabolite of heroin, was detected in fewer cases and at lower concentrations than was morphine (a product of the metabolism of 6AM). The fast metabolization of cocaine resulted in its being detected in fewer cases than was BEG, its main metabolite.
